If the review runs on a standard timeline, CagriSema could be available in the U.S
The report highlights early metabolic studies, selected clinical trials, and certain double-blind placebo-controlled investigations that examined markers such as: blood sugar regulation insulin sensitivity cholesterol levels impaired glucose tolerance adipose tissue activity fat release and lipolytic activity While these studies generated interest in AOD-9604 as a potential anti-obesity drug candidate , the report stresses that no authority recognizes it as an active treatment for obesity, weight loss, or human use and emphasizes that it remains designated strictly for research use
Resistant to stomach acid and stable at room temperature, it has shown remarkable regenerative effects in preclinical studies, particularly for gastrointestinal healing
Follow-up visits: mid-cycle and end-of-cycle, either in person or hybrid depending on stability
J Biol Chem 2004
To learn how this ties into broader systemic recovery, see Unlocking the Healing Power of BPC-157: Benefits, Uses, and Science Explained
